| Literature DB >> 24962791 |
Danilo Swann Matassa1, Ilenia Agliarulo1, Maria Rosaria Amoroso1, Francesca Maddalena2, Leandra Sepe3, Maria Carla Ferrari3, Vinay Sagar4, Silvia D'Amico4, Fabrizio Loreni4, Giovanni Paolella3, Matteo Landriscina5, Franca Esposito6.
Abstract
TNF receptor-associated protein 1 (TRAP1) is an HSP90 chaperone involved in stress protection and apoptosis in mitochondrial and extramitochondrial compartments. Remarkably, aberrant deregulation of TRAP1 function has been observed in several cancer types with potential new opportunities for therapeutic intervention in humans. Although previous studies by our group identified novel roles of TRAP1 in quality control of mitochondria-destined proteins through the attenuation of protein synthesis, molecular mechanisms are still largely unknown. To shed further light on the signaling pathways regulated by TRAP1 in the attenuation of protein synthesis, this study demonstrates that the entire pathway of cap-mediated translation is activated in cells following TRAP1 interference: consistently, expression and consequent phosphorylation of p70S6K and RSK1, two translation activating kinases, are increased upon TRAP1 silencing. Furthermore, we show that these regulatory functions affect the response to translational stress and cell migration in wound healing assays, processes involving both kinases. Notably, the regulatory mechanisms controlled by TRAP1 are conserved in colorectal cancer tissues, since an inverse correlation between TRAP1 and p70S6K expression is found in tumor tissues, thereby supporting the relevant role of TRAP1 translational regulation in vivo. Taken as a whole, these new findings candidate TRAP1 network for new anti-cancer strategies aimed at targeting the translational/quality control machinery of tumor cells.Entities:
Keywords: Cell migration; Colorectal carcinoma; Ribavirin; TRAP1; Translation control; Wound healing
Mesh:
Substances:
Year: 2014 PMID: 24962791 PMCID: PMC5528605 DOI: 10.1016/j.molonc.2014.06.003
Source DB: PubMed Journal: Mol Oncol ISSN: 1574-7891 Impact factor: 6.603